Ligand Pharmaceuticals Incorporated (LGNDV) Stock Analysis
DELISTED
What happened to Ligand Pharmaceuticals Incorporated (LGNDV) stock?
Ligand Pharmaceuticals Incorporated (LGNDV) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 28.04 means the share price is 28.04 times one year of earnings per share.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Ligand Pharmaceuticals Incorporated (LGNDV). Ligand Pharmaceuticals Incorporated focuses on developing and acquiring technologies to aid pharmaceutical companies in discovering and developing medicines globally. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, and various other diseases.
Last analyzed: Mar 18, 2026Ligand Pharmaceuticals Incorporated (LGNDV) Healthcare & Pipeline Overview
More about this archive record
Can I still buy LGNDV shares?
No. LGNDV stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for LGNDV elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before LGNDV stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Ligand Pharmaceuticals Incorporated. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.